Estrogen signalling and the metabolic syndrome: targeting the hepatic estrogen receptor alpha action.
An increasing body of evidence now links estrogenic signalling with the metabolic syndrome (MS). Despite the beneficial estrogenic effects in reversing some of the MS symptoms, the underlying mechanisms remain largely undiscovered. We have previously shown that total estrogen receptor alpha (ERα) kn...
Main Authors: | Marko Matic, Galyna Bryzgalova, Hui Gao, Per Antonson, Patricia Humire, Yoko Omoto, Neil Portwood, Camilla Pramfalk, Suad Efendic, Per-Olof Berggren, Jan-Åke Gustafsson, Karin Dahlman-Wright |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3581463?pdf=render |
Similar Items
-
Correction: Estrogen Signalling and the Metabolic Syndrome: Targeting the Hepatic Estrogen Receptor Alpha Action.
by: Marko Matic, et al.
Published: (2019-01-01) -
aP2-Cre-mediated inactivation of estrogen receptor alpha causes hydrometra.
by: Per Antonson, et al.
Published: (2014-01-01) -
Impact of estrogen receptor gene polymorphisms and mRNA levels on obesity and lipolysis – a cohort study
by: Arner Peter, et al.
Published: (2007-12-01) -
Effects of two common polymorphisms in the 3' untranslated regions of estrogen receptor β on mRNA stability and translatability
by: Gustafsson Jan-Åke, et al.
Published: (2009-09-01) -
Measuring the binding kinetics of estrogen receptor alpha and dietary estrogens
by: Lee, Isaish Chi Kin
Published: (2014)